NEW YORK (Reuters) – Shares of retirement services provider Corebridge Financial fell more than 6% on Tuesday as parent American International Group Inc looks to sell down its controlling stake. Insurance giant AIG will sell 65 million shares, or about 10% of its total Corebridge holding, which is valued at nearly $1.1 billion. The share…
By Julie Steenhuysen CHICAGO (Reuters) – Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a mid-stage trial, the companies reported on Monday. With this and earlier data, Moderna is considering seeking…
(This May 31 story has been corrected to fix the spelling of executive’s name to Teresa, not Theresa, in paragraph 5) By Michael Erman (Reuters) – Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to…
By Brendan Pierson (Reuters) – Texas and an anonymous anti-abortion activist made a joint court filing over the weekend, urging a federal judge to decide a $1.8 billion fraud lawsuit they brought against Planned Parenthood in their favor, saying a recent U.S. Supreme Court ruling strengthened the case. The lawsuit, before U.S. District Judge Matthew…
By Nelson Bocanegra BOGOTA (Reuters) – Colombia’s lower house on Monday said it would freeze debates on government-backed social reforms, as former high-ranking officials in President Gustavo Petro’s administration were called to give evidence over alleged campaign financing irregularities. The government of leftist Petro, who took office last year, has sent proposed labor, pension and…
By Rachael Levy, Krystal Hu and Marisa Taylor (Reuters) – Elon Musk’s brain implant startup Neuralink, which was valued at close to $2 billion in a private fundraising round two years ago, is now worth around $5 billion based on privately executed stock trades described to Reuters by five sources with knowledge of the matter….
By Patrick Wingrove (Reuters) – Johnson & Johnson’s legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis treatment Stelara until January 2025 could make the drug a larger contributor to J&J’s 2024 and 2025 sales than Wall Street is forecasting. Stelara, introduced in 2009, has been J&J’s top-selling drug since…
By Leroy Leo (Reuters) – UnitedHealth Group on Monday made a surprise $3.26 billion all-cash offer to acquire Amedisys Inc, pitting itself against another healthcare company set to buy the home health and hospice care firm. Interest in the home health sector has jumped since the pandemic as patients and caregivers increasingly prefer accessing medical…
By Emma Farge GENEVA (Reuters) – The United States and several other countries have committed human rights violations against a Saudi man held in the Guantanamo prison and accused of organising the bombing of the USS Cole in the port of Aden in 2000, a U.N. report said. Abd al Rahim al Nashiri could face…
(Reuters) -At least 16 people have died and dozens more have fallen ill after drinking adulterated cider in western Russia’s Ulyanovsk region, local officials said on Monday. Local governor Alexei Russkikh said the product – labelled “Mister Cider” – had been sold on tap after being brought into the region in 30 litre kegs. According…
